3081 - 3090 of 6230 Results
Title
Year
- Methodological considerations in neuronal extracellular vesicle isolation for α-synuclein biomarkers2023OPENTitle: Methodological considerations in neuronal extracellular vesicle isolation for α-synuclein biomarkersJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 146Issue #: 11Start Page: e95End Page: e97Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1093/brain/awad169Best OA location URL: https://academic.oup.com/brain/advance-article-pdf/doi/10.1093/brain/awad169/50433441/awad169.pdfCitation Count: 10
- Alpha‐Synuclein Oligomers and Neurofilament Light Chain Predict Phenoconversion of Pure Autonomic Failure2021OPENTitle: Alpha‐Synuclein Oligomers and Neurofilament Light Chain Predict Phenoconversion of Pure Autonomic FailureJournal Name: Annals of NeurologyPublisher: WileyVol: 89Issue #: 6Start Page: 1212End Page: 1220Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/ana.26089Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/8168720Citation Count: 77
- No genetic evidence for involvement of alcohol dehydrogenase genes in risk for Parkinson's disease2019OPENTitle: No genetic evidence for involvement of alcohol dehydrogenase genes in risk for Parkinson's diseaseJournal Name: Neurobiology of AgingPublisher: Elsevier BVVol: 87Issue #:Start Page: 140.e19End Page: 140.e22Publication Date:Open Access(OA) Status: OPENLicense: other-oaDOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2019.11.006Best OA location URL: https://www.sciencedirect.com/science/article/am/pii/S0197458019303951Citation Count: 13
-
OPENTitle: Sequence of clinical and neurodegeneration events in Parkinson’s disease progressionJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 144Issue #: 3Start Page: 975End Page: 988Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1093/brain/awaa461Best OA location URL: https://academic.oup.com/brain/article-pdf/144/3/975/37036706/awaa461.pdfCitation Count: 83
-
OPENTitle: White Matter Hyperintensities Related to Parkinson's Disease Executive FunctionJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 7Issue #: 6Start Page: 629End Page: 638Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mdc3.12956Best OA location URL: https://movementdisorders.onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.12956Citation Count: 47
- Intra‐ and inter‐network functional alterations in Parkinson's disease with mild cognitive impairment2017OPENTitle: Intra‐ and inter‐network functional alterations in Parkinson's disease with mild cognitive impairmentJournal Name: Human Brain MappingPublisher: WileyVol: 38Issue #: 3Start Page: 1702End Page: 1715Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/hbm.23499Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/6866883Citation Count: 59
-
OPENTitle: L-DOPA functionalized, multi-branched gold nanoparticles as brain-targeted nano-vehiclesJournal Name: Nanomedicine: Nanotechnology, Biology and MedicinePublisher: Elsevier BVVol: 15Issue #: 1Start Page: 1End Page: 11Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.nano.2018.08.011Best OA location URL: http://hdl.handle.net/10044/1/63483Citation Count: 87
- α-Synuclein-specific T cell reactivity is associated with preclinical and early Parkinson’s disease2020OPENTitle: α-Synuclein-specific T cell reactivity is associated with preclinical and early Parkinson’s diseaseJournal Name: Nature CommunicationsPublisher: Springer Science and Business Media LLCVol: 11Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41467-020-15626-wBest OA location URL: https://www.nature.com/articles/s41467-020-15626-w.pdfCitation Count: 339
-
OPENTitle: Six Action Steps to Address Global Disparities in Parkinson DiseaseJournal Name: JAMA NeurologyPublisher: American Medical Association (AMA)Vol: 79Issue #: 9Start Page: 929End Page: 929Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1001/jamaneurol.2022.1783Best OA location URL: https://jamanetwork.com/journals/jamaneurology/articlepdf/2793874/jamaneurology_schiess_2022_sc_220001_1662471546.98796.pdfCitation Count: 95
- Biomarkers of neurodegeneration and glial activation validated in Alzheimer’s disease assessed in longitudinal cerebrospinal fluid samples of Parkinson’s disease2021OPENTitle: Biomarkers of neurodegeneration and glial activation validated in Alzheimer’s disease assessed in longitudinal cerebrospinal fluid samples of Parkinson’s diseaseJournal Name: PLOS ONEPublisher: Public Library of Science (PLoS)Vol: 16Issue #: 10Start Page: e0257372End Page: e0257372Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1371/journal.pone.0257372Best OA location URL: https://escholarship.org/content/qt6cf8k71w/qt6cf8k71w.pdfCitation Count: 35